Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Frauke Rudolf. (2014) The Bandim TBscore – reliability, further development, and evaluation of potential uses. Global Health Action 7:1.
Read now
Read now
Articles from other publishers (34)
Anders Solitander Bohlbro, Bo Langhoff Hønge, Thomas Engell-Sørensen, Antonio Matteus Mendes, Armando Sifna, Victor Gomes, Frauke Rudolf & Christian Wejse. (2023) Life expectancy among patients with pulmonary tuberculosis is less than one-third of life expectancy in the background population in Guinea-Bissau—an observational study. International Journal of Epidemiology 52:4, pages 1112-1123.
Crossref
Crossref
Anders Solitander Bohlbro, Antonio Matteus Mendes, Armando Sifna, Victor Gomes, Frauke Rudolf & Christian Wejse. (2022) Incidence of pulmonary tuberculosis in suburban Bissau, Guinea-Bissau between 2004 and 2020: a prospective cohort study. Infection 51:4, pages 955-966.
Crossref
Crossref
Anders Solitander Bohlbro, Antonio Matteus Mendes, Armando Sifna, Cecilie Blenstrup Patsche, Martin Emil Schomann Soelberg, Victor Gomes, Christian Wejse & Frauke Rudolf. (2023) BCG is protective against death in male but not female patients with pulmonary tuberculosis in Guinea-Bissau. Transactions of The Royal Society of Tropical Medicine and Hygiene 117:5, pages 365-374.
Crossref
Crossref
Haoyue Zhang, Yuying He, Lina Davies Forsman, Jakob Paues, Jim Werngren, Katarina Niward, Thomas Schön, Judith Bruchfeld, Jan-Willem Alffenaar & Yi Hu. (2023) Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis. Frontiers in Pharmacology 13.
Crossref
Crossref
Claire J Calderwood, Byron WP Reeve, Tiffeney Mann, Zaida Palmer, Georgina Nyawo, Hridesh Mishra, Gcobisa Ndlangalavu, Ibrahim Abubakar, Mahdad Noursadeghi, Grant Theron & Rishi K Gupta. (2023) Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults. Journal of Infection 86:1, pages 24-32.
Crossref
Crossref
Alexander Dutschke, Ditte Steiniche, Sanne Jespersen, Joao Paulo Nanque, Candida Medina, Bo Langhoff Hønge & Christian Wejse. (2022) Xpert MTB/RIF on urine samples to increase diagnosis of TB in people living with HIV in Guinea-Bissau. International Journal of Infectious Diseases 124, pages S63-S68.
Crossref
Crossref
Aimée Bert-Dulanto, Esteban A. Alarcón-Braga, Ana Castillo-Soto & Raffo Escalante-Kanashiro. (2022) Predicting mortality in pulmonary tuberculosis: A systematic review of prognostic models. Indian Journal of Tuberculosis 69:4, pages 432-440.
Crossref
Crossref
Jan Heyckendorf, Sophia B. Georghiou, Nicole Frahm, Norbert Heinrich, Irina Kontsevaya, Maja Reimann, David Holtzman, Marjorie Imperial, Daniela M. Cirillo, Stephen H. Gillespie & Morten Ruhwald. (2022) Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies. Clinical Microbiology Reviews 35:3.
Crossref
Crossref
Xubin Zheng, Lina Davies Forsman, Ziwei Bao, Yan Xie, Zhu Ning, Thomas Schön, Judith Bruchfeld, Biao Xu, Jan-Willem Alffenaar & Yi Hu. (2022) Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China. European Respiratory Journal 59:3, pages 2101925.
Crossref
Crossref
David Ekqvist, Anna Bornefall, Daniel Augustinsson, Martina Sönnerbrandt, Michaela Jonsson Nordvall, Mats Fredrikson, Björn Carlsson, Mårten Sandstedt, Ulrika S H Simonsson, Jan-Willem C Alffenaar, Jakob Paues & Katarina Niward. (2022) Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP). BMJ Open 12:3, pages e054788.
Crossref
Crossref
Chandrani Thakur, Ashutosh Tripathi, Sathyabaarathi Ravichandran, Akshatha Shivananjaiah, Anushree Chakraborty, Sreekala Varadappa, Nagaraj Chikkavenkatappa, Deepesh Nagarajan, Sharada Lakshminarasimhaiah, Amit Singh & Nagasuma Chandra. (2022) A new blood-based RNA signature (R9), for monitoring effectiveness of tuberculosis treatment in a South Indian longitudinal cohort. iScience 25:2, pages 103745.
Crossref
Crossref
Kamran Siddiqi, Ada Keding, Anna-Marie Marshall, Omara Dogar, Jinshuo Li, Rumana Huque, Razia Fatima, Amina Khan, Helen Elsey, Rhian Gabe, Daniel Kotz & Aziz Sheikh. (2022) Effect of quitting smoking on health outcomes during treatment for tuberculosis: secondary analysis of the TB & Tobacco Trial. Thorax 77:1, pages 74-78.
Crossref
Crossref
Frauke Rudolf, Ebba Abate, Binyam Moges, Antonio Mateus Mendes, Mezgebu Yitayal Mengistu, Armando Sifna, Hikma Fekadu, Segenet Bizuneh, Thomas Schön & Christian Wejse. (2021) Increasing smear positive tuberculosis detection using a clinical score – A stepped wedge multicenter trial from Africa. International Journal of Infectious Diseases 113, pages S55-S62.
Crossref
Crossref
Anders Solitander Bohlbro, Antonio Matteus Mendes, Armando Sifna, Cecilie Blenstrup Patsche, Victor Gomes, Christian Wejse & Frauke Rudolf. (2021) Assessing gender differences among presumed and diagnosed patients with pulmonary TB: observations from Guinea-Bissau. Transactions of The Royal Society of Tropical Medicine and Hygiene 115:11, pages 1273-1281.
Crossref
Crossref
Surinder Pal SinghDrDrHarjinder SinghDrDrKomal Deep KaurDrDrKailash MeenaDrDrAshish ShuklaDrDrAjayPal SinghDrDrRenu BediDrDrKamaldeep SinghDrDrJyoti JyotiDrDr. (2021) THE IMPORTANCE OF CHEST-X-RAY (TIMIKA SCORE) TO PREDICT THE CLINICO-BACTERIOLOGICAL PROFILE OF PULMONARY TUBERCULOSIS PATIENTS. INDIAN JOURNAL OF APPLIED RESEARCH, pages 55-58.
Crossref
Crossref
Charissa C. Naidoo, Georgina R. Nyawo, Imran Sulaiman, Benjamin G. Wu, Carolin T. Turner, Kevin Bu, Zaida Palmer, Yonghua Li, Byron W.P. Reeve, Suventha Moodley, Jennifer G. Jackson, Jason Limberis, Andreas H. Diacon, Paul D. van Helden, Jose C. Clemente, Robin M. Warren, Mahdad Noursadeghi, Leopoldo N. Segal & Grant Theron. (2021) Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis. EBioMedicine 67, pages 103374.
Crossref
Crossref
Lauren S. Peetluk, Felipe M. Ridolfi, Peter F. Rebeiro, Dandan Liu, Valeria C Rolla & Timothy R. Sterling. (2021) Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults. BMJ Open 11:3, pages e044687.
Crossref
Crossref
Kiros Tedla, Girmay Medhin, Gebretsadik Berhe, Afework Mulugeta & Nega Berhe. (2020) Delay in treatment initiation and its association with clinical severity and infectiousness among new adult pulmonary tuberculosis patients in Tigray, northern Ethiopia. BMC Infectious Diseases 20:1.
Crossref
Crossref
Omara Dogar, Ada Keding, Rhian Gabe, Anna-Marie Marshall, Rumana Huque, Deepa Barua, Razia Fatima, Amina Khan, Raana Zahid, Sonia Mansoor, Daniel Kotz, Melanie Boeckmann, Helen Elsey, Eva Kralikova, Steve Parrott, Jinshuo Li, Anne Readshaw, Aziz Sheikh & Kamran Siddiqi. (2020) Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. The Lancet Global Health 8:11, pages e1408-e1417.
Crossref
Crossref
Anurag Bhargava & Madhavi Bhargava. (2020) Tuberculosis deaths are predictable and preventable: Comprehensive assessment and clinical care is the key. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 19, pages 100155.
Crossref
Crossref
Carolin T Turner, Rishi K Gupta, Evdokia Tsaliki, Jennifer K Roe, Prasenjit Mondal, Georgina R Nyawo, Zaida Palmer, Robert F Miller, Byron WP Reeve, Grant Theron & Mahdad Noursadeghi. (2020) Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study. The Lancet Respiratory Medicine 8:4, pages 407-419.
Crossref
Crossref
Hridesh Mishra, Byron W P Reeve, Zaida Palmer, Judy Caldwell, Tania Dolby, Charissa C Naidoo, Jennifer G Jackson, Samuel G Schumacher, Claudia M Denkinger, Andreas H Diacon, Paul D van Helden, Florian M Marx, Robin M Warren & Grant Theron. (2020) Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study. The Lancet Respiratory Medicine 8:4, pages 368-382.
Crossref
Crossref
Johanna Wøldike Aunsborg, Bo Langhoff Hønge, Sanne Jespersen, Frauke Rudolf, Candida Medina, Faustino Gomes Correira, Isik Somuncu Johansen & Christian Wejse. (2020) A clinical score has utility in tuberculosis case-finding among patients with HIV: A feasibility study from Bissau. International Journal of Infectious Diseases 92, pages S78-S84.
Crossref
Crossref
Rajagopalan Saranathan, Pattabiraman Sathyamurthi, Kannan Thiruvengadam, Selvachithiram Murugesan, Shri Vijay Bala Yogendra Shivakumar, Narayanan Sivaramakrishnan Gomathi, Dhanasekaran Kavitha, Mandar Paradkar, Rohini Puvaneshwari, Muthuramalingam Kannan, Annamalai Madheswaran, Neeta Pradhan, Vandana Kulkarni, Akshay N. Gupte, Nikhil Gupte, Vidya Mave, Robert C. Bollinger, Amita Gupta, Chandrasekaran Padmapriyadarsini & Luke Elizabeth Hanna. (2020) MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patients. Infection, Genetics and Evolution 77, pages 104093.
Crossref
Crossref
Katarina Niward, Lina Davies Forsman, Judith Bruchfeld, Erja Chryssanthou, Oskar Carlström, Teba Alomari, Björn Carlsson, Anton Pohanka, Mikael Mansjö, Michaela Jonsson Nordvall, Anders G Johansson, Erik Eliasson, Jim Werngren, Jakob Paues, Ulrika S H Simonsson & Thomas Schön. (2018) Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting. Journal of Antimicrobial Chemotherapy 73:10, pages 2838-2845.
Crossref
Crossref
Lina Davies Forsman, Katarina Niward, Yi Hu, Rongrong Zheng, Xubin Zheng, Ran Ke, Weiping Cai, Chao Hong, Yang Li, Yazhou Gao, Jim Werngren, Jakob Paues, Johanna Kuhlin, Ulrika S H Simonsson, Erik Eliasson, Jan-Willem Alffenaar, Mikael Mansjö, Sven Hoffner, Biao Xu, Thomas Schön & Judith Bruchfeld. (2018) Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study. BMJ Open 8:9, pages e023899.
Crossref
Crossref
Omara Dogar, Deepa Barua, Melanie Boeckmann, Helen Elsey, Razia Fatima, Rhian Gabe, Rumana Huque, Ada Keding, Amina Khan, Daniel Kotz, Eva Kralikova, James N. Newell, Iveta Nohavova, Steve Parrott, Anne Readshaw, Lottie Renwick, Aziz Sheikh & Kamran Siddiqi. (2018) The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. Addiction 113:9, pages 1716-1726.
Crossref
Crossref
C. Lange, W. A. Alghamdi, M. H. Al-Shaer, S. Brighenti, A. H. Diacon, A. R. DiNardo, H. P. Grobbel, M. I. Gröschel, F. von Groote-Bidlingmaier, M. Hauptmann, J. Heyckendorf, N. Köhler, T. A. Kohl, M. Merker, S. Niemann, C. A. Peloquin, M. Reimann, U. E. Schaible, D. Schaub, V. Schleusener, T. Thye & T. Schön. (2018) Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. Journal of Internal Medicine 284:2, pages 163-188.
Crossref
Crossref
Jordi Rello, Oriol Manuel, Philippe Eggimann, Guy Richards, Christian Wejse, Jorgen Eskild Petersen, Kai Zacharowski & Hakan Leblebicioglu. (2016) Management of infections in critically ill returning travellers in the intensive care unit—II: clinical syndromes and special considerations in immunocompromised patients. International Journal of Infectious Diseases 48, pages 104-112.
Crossref
Crossref
Karen B. Jacobson, Anthony P. Moll, Gerald H. Friedland & Sheela V. Shenoi. (2015) Successful Tuberculosis Treatment Outcomes among HIV/TB Coinfected Patients Down-Referred from a District Hospital to Primary Health Clinics in Rural South Africa. PLOS ONE 10:5, pages e0127024.
Crossref
Crossref
C. Wejse, C.B. Patsche, A. Kühle, F.J.V. Bamba, M.S. Mendes, G. Lemvik, V.F. Gomes & F. Rudolf. (2015) Impact of HIV-1, HIV-2, and HIV-1+2 dual infection on the outcome of tuberculosis. International Journal of Infectious Diseases 32, pages 128-134.
Crossref
Crossref
T. T. Balcha, S. Skogmar, E. Sturegård, T. Schön, N. Winqvist, A. Reepalu, Z. H. Jemal, G. Tibesso, J. Björk & P. Björkman. (2014) A Clinical Scoring Algorithm for Determination of the Risk of Tuberculosis in HIV-Infected Adults: A Cohort Study Performed at Ethiopian Health Centers. Open Forum Infectious Diseases 1:3.
Crossref
Crossref
Jan Heyckendorf, Ioana D. Olaru, Morten Ruhwald & Christoph Lange. (2014) Getting Personal Perspectives on Individualized Treatment Duration in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis. American Journal of Respiratory and Critical Care Medicine 190:4, pages 374-383.
Crossref
Crossref
J. Virenfeldt, F. Rudolf, C. Camara, A. Furtado, V. Gomes, P. Aaby, E. Petersen & C. Wejse. (2014) Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study. BMJ Open 4:6, pages e004818-e004818.
Crossref
Crossref